0001095981-20-000002.txt : 20200522 0001095981-20-000002.hdr.sgml : 20200522 20200521183337 ACCESSION NUMBER: 0001095981-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200521 EFFECTIVENESS DATE: 20200522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367505 FILM NUMBER: 20903262 BUSINESS ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 737.255.7194 MAIL ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050712 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 D 1 primary_doc.xml X0708 D LIVE 0001095981 PLUS THERAPEUTICS, INC. 4200 MARATHON BLVD. SUITE 200 AUSTIN TX TEXAS 78756 737.255.7194 DELAWARE CYTORI THERAPEUTICS, INC. MACROPORE INC Corporation true Marc H. Hedrick 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Executive Officer Director Andrew Sims 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Executive Officer Howard Clowes 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Director An van Es-Johansson 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Director Richard J. Hawkins 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Director Robert Lenk 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Director Greg Petersen 4200 MARATHON BLVD., SUITE 200 Austin TX TEXAS 78756 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-08 false true false The securities issued were share consideration under the License Agreement between the issuer and NanoTx, Corp. 0 300000 300000 0 true 1 1 0 0 0 false PLUS THERAPEUTICS, INC. /s/ Andrew Sims Andrew Sims Chief Financial Officer 2020-05-21